Advantage from massive parallel sequencing of RYR1 and CACNA1S in diagnostics of malignant hyperthermia susceptibility

被引：0
|
作者：
Dorota Fiszer
Nickla A Fisher
Ian M Carr
Marie-Anne Shaw
Philip M Hopkins
机构：
[1] School of Medicine,Leeds Institute of Biomedical & Clinical Sciences
[2] University of Leeds,Malignant Hyperthermia Investigation Unit
[3] St James’s University Hospital,undefined
来源：
BMC Anesthesiology | / 14卷 / Suppl 1期
关键词：
Malignant Hyperthermia; Malignant Hyperthermia; Massive Parallel Sequencing; Malignant Hyperthermia Susceptibility; Exertional Heat Stroke;
D O I：
10.1186/1471-2253-14-S1-A13
中图分类号：
学科分类号：
摘要：
引用
收藏
相关论文
共 50 条
  • [1] Next-generation Sequencing of RYR1 and CACNA1S in Malignant Hyperthermia and Exertional Heat Illness
    Fiszer, Dorota
    Shaw, Marie-Anne
    Fisher, Nickla A.
    Carr, Ian M.
    Gupta, Pawan K.
    Watkins, Elizabeth J.
    de Sa, Daniel Roiz
    Kim, Jerry H.
    Hopkins, Philip M.
    ANESTHESIOLOGY, 2015, 122 (05) : 1033 - 1046
  • [2] Bayesian modeling to predict malignant hyperthermia susceptibility and pathogenicity of RYR1, CACNA1S and STAC3 variants
    Sadhasivam, Senthilkumar
    Brandom, Barbara W.
    Henker, Richard A.
    McAuliffe, John J.
    PHARMACOGENOMICS, 2019, 20 (14) : 989 - 1003
  • [3] Comparison of pathogenicity prediction tools on missense variants in RYR1 and CACNA1S associated with malignant hyperthermia
    Schiemann, A. H.
    Stowell, K. M.
    BRITISH JOURNAL OF ANAESTHESIA, 2016, 117 (01) : 124 - 128
  • [4] Sequencing the CACNA1S gene in patients susceptible to malignant hyperthermia
    Leo, V.
    Ringrose, C.
    Carpenter, D.
    Robinson, R. L.
    Halsall, P. J.
    Booms, P.
    Steele, D.
    Iles, D. E.
    Shaw, M. -A.
    Hopkins, P. M.
    BRITISH JOURNAL OF ANAESTHESIA, 2008, 100 (04) : 588P - 588P
  • [5] The role of CACNA1S in predisposition to malignant hyperthermia
    Carpenter, Danielle
    Ringrose, Christopher
    Leo, Vincenzo
    Morris, Andrew
    Robinson, Rachel L.
    Halsall, P. Jane
    Hopkins, Philip M.
    Shaw, Marie-Anne
    BMC MEDICAL GENETICS, 2009, 10 : 104
  • [6] Updating probability of pathogenicity for RYR1 and CACNA1S exon variants in individuals without malignant hyperthermia after exposure to triggering anesthetics
    Roberts, David A.
    Bastarache, Lisa
    He, Jing
    Lewis, Adam
    Aka, Ida T.
    Shotwell, Matthew S.
    Reddy, Srijaya K.
    Hogan, Kirk J.
    Biesecker, Leslie G.
    Kertai, Miklos D.
    PHARMACOGENETICS AND GENOMICS, 2025, 35 (02): : 65 - 72
  • [7] Pharmacogenetics and pathophysiology of CACNA1S mutations in malignant hyperthermia
    Beam, Teresa A.
    Loudermilk, Emily F.
    Kisor, David F.
    PHYSIOLOGICAL GENOMICS, 2017, 49 (02) : 81 - 87
  • [8] RYR1 and CACNA1S genetic variants identified with statin-associated muscle symptoms
    Isackson, Paul J.
    Wang, Jianxin
    Zia, Mohammad
    Spurgeon, Paul
    Levesque, Adrian
    Bard, Jonathan
    James, Smitha
    Nowak, Norma
    Lee, Tae Keun
    Vladutiu, Georgirene D.
    PHARMACOGENOMICS, 2018, 19 (16) : 1235 - 1249
  • [9] Ryanodine receptor gene (RYR1) mutations for diagnosing susceptibility to malignant hyperthermia
    Urwyler, A
    Halsall, PJ
    Mueller, C
    Robinson, R
    ACTA ANAESTHESIOLOGICA SCANDINAVICA, 2003, 47 (04) : 492 - 492
  • [10] Functional analysis of RYR1 variants in patients with confirmed susceptibility to malignant hyperthermia
    White, Ruth
    Schiemann, Anja H.
    Burling, Sophie M.
    Bjorksten, Andrew
    Bulger, Terasa
    Gillies, Robyn
    Hopkins, Philip M.
    Kamsteeg, Erik-Jan
    Machon, Roslyn G.
    Massey, Sean
    Miller, Dorota
    Perry, Margaret
    Snoeck, Marc M. J.
    Stephens, Jeremy
    Street, Neil
    van den Bersselaar, Luuk R.
    Stowell, Kathryn M.
    BRITISH JOURNAL OF ANAESTHESIA, 2022, 129 (06) : 879 - 888
12345